MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Venture Capital: Risk Capital_Angel, Venture, Sovereign Wealth Investor Companies & Organizations
*Portfolio Companies: Healthcare Ventures
FoldRx Pharmaceuticals
Parents
*Architects: Neurology, Psychology, Mental Health, CNS, Pain & TBI Companies (Pharmaceuticals, Drugs, Biotechnology, Biosimilars)
*Industry: Massachusetts
*Portfolio Companies: Alta
*Portfolio Companies: Healthcare Ventures
Architects: Biotechnology_Proteomics
Companies: Acquired_(M&A)
Finance & Acquisition: Pfizer
Pfizer:Acquisitions
Children
2010: Pfizer completes FoldRX Acquisition (2010)
Cambridge, Massachusetts
Lead molecule for a neurodegenerative disorder called TTR amyloid polyneuropathy, which affects a mere 8,000 patients worldwide
Richard Labaudiniere, FoldRx’s president and chief executive
Small molecule therapeutics to treat diseases of protein misfolding and aggregation (amyloidosis)